← Top stories
Broker call▲ Bullish for Molbio Diagnostics
Stocks to Buy: A new listing has become Jefferies' latest 'high-conviction top pick'; Check upside targets
The brief
- Jefferies named Molbio Diagnostics its latest high-conviction top pick
- The company has commercialized a point-of-care molecular diagnostics platform
- Molbio’s diagnostics business is relevant to Indian healthcare investors
- Jefferies sees HDFC Bank rerating potential tied to CEO succession and execution
- BSE shares fall 2%, down 30% in 4 months. Why Macquarie is bullish while Jefferies is cautious